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Introduction
At least 80% of cancers arise from epithelial cells. In many tumours a change in cell type, referred to as metaplasia, is a key step in cancer initiation. Barrett's esophagus (BE) is an example of metaplasia in the distal esophagus and affects 1 in 50 people 1 . BE is defined as replacement of squamous epithelium by columnar epithelium, and it gives a 30-fold increased risk of developing esophageal adenocarcinoma (EAC) which is highly fatal [2] [3] [4] . BE is associated with gastroesophageal reflux disease, suggesting it occurs in response to a chronically inflamed environment 5 . Remarkably, several anatomically distant cell types are also identifiable in BE, most commonly intestinal goblet cells but also Paneth and pancreatic acinar cells, among others [6] [7] [8] .
This apparent plasticity in BE has obscured its relationship with normal gastrointestinal tissues, as no normal gastrointestinal tissue has the extent of cellular heterogeneity as BE.
The current most widely held view is that BE originates from the stomach 9, 10 , and studies looking for similarities (e.g. in gene or protein expression and cellular appearance) between BE and selected normal tissues -including the intestine, gastric pylorus, gastric corpus and gastric cardia -have found some shared attributes 11 . However, to complicate matters, there is evidence suggesting BE may originate directly from native esophageal cells [12] [13] [14] [15] , from recruitment of circulating stem cells 16 , or from reactivation of dormant progenitor cells in situ 17 . Therefore, BE characterizations that focus on characteristics of gastric or intestinal columnar epithelia are inherently compromised. A more unbiased and systematic approach to BE characterization in humans is required, not least because BE has been observed after gastric resection 18 , which conflicts with described theories of BE development, rodents and humans have differences in their gastrointestinal tract (such as rodents lacking esophageal glands), and similarities between gastric heterotopia and BE.
Single cell RNA-sequencing (RNA-seq), combined with computational methods for functional clustering of cell types, provides an unbiased approach to understanding cellular heterogeneity. Applying this to human tissues is challenging, but is currently the best way to perform unbiased functional assessment of cells from BE and related normal tissues, with the potential to identify unique cell types and propose new markers of specialised cell types in BE, with implications for how BE can be detected and diagnosed.
Given the highly heterogeneous nature of BE, we hypothesised that single cell RNA-seq might clarify the relationships between cells in normal tissues and BE, and indicate whether there are specialised cells in BE with similar functions to cells elsewhere in the non-inflamed gastrointestinal tract. Therefore we applied this approach to biopsies from BE, esophagus, stomach and small intestine (duodenum). This revealed a cell population in BE that expresses the developmental gene (LEFTY1) and is distinct from all tested intestinal or gastric cells, but was transcriptionally highly similar to rare columnar cells from normal esophagus.
Results

Single cell RNA-seq identifies subpopulations in normal upper gastrointestinal epithelia
To characterise the cell populations in BE, samples were taken from seven patients attending for routine endoscopic surveillance of non-dysplastic BE previously noted to have intestinal metaplasia. From each patient, we took biopsies from BE, adjacent macroscopically normal esophagus (minimum 20mm proximal to BE), stomach (10-20mm distal to the gastroesophageal junction) and duodenum (Figure 1a) . Individual 2mm biopsies were divided to provide tissue for single cell RNA-seq, bulk tissue RNA-seq and histology in four patients, and bulk tissue RNA-seq and histology in three patients (see Methods). Single cells were also prepared from normal esophageal biopsies from two control patients with gastroesophageal reflux disease but no previous or current diagnosis of BE or any other esophageal pathology. All sampled patients were taking regular acid suppression therapy and had no features of esophageal dysplasia or malignancy (Extended Data Table 1 ).
Bulk RNA-sequencing followed by hierarchical clustering of differentially expressed genes in the duodenal, gastric, esophageal and BE samples from the 7 patients with BE showed a clear distinction between squamous (i.e. normal esophagus) and non-squamous (i.e. gastric, duodenum and BE) epithelia (Figure 1b) . BE samples from all 7 patients had some similarities to duodenal and gastric samples (Figure 1b) . When a defined list of genes known to distinguish gastrointestinal epithelia 11 was used in hierarchical clustering, all BE samples appeared most closely related to gastric tissue, consistent with previous studies 9 (Figure 1c) .
To gain insights into the cellular heterogeneity of these tissues, we analysed the transcriptomes of 2176 single cells from four BE patients (620 BE cells; 526 adjacent normal esophagus cells; 678 gastric cells; and 352 duodenum cells) and 719 normal esophageal cells from two control patients. A mean of 1.4x10 5 reads were mapped per cell and a median of 4484 genes/cell were detected (with at least one read per cell) in cells included in the analysis. Based on data from positive (neural RNA diluted to 10pg) and negative (only spikein control) samples, cells with fewer than 25119 total mapped reads were excluded, leaving a total of 1778 cells for further analysis (see Methods).
First, we clustered the cells from each normal tissue type from the BE patients by gene expression (Figure 1d) . The eleven clusters (D1-D4, G1-G3 and E1-E4, in duodenum, gastric and esophagus samples, respectively) were then annotated on the basis of genes previously characterized as expressed in specific cell types (complete list in Supplementary Table 1 ).
In duodenum, these are: intestinal alkaline phosphatase (ALPI) expressing enterocytes (D1); mucin 2 (MUC2) expressing goblet cells (D2); olfactomedin 4 (OLFM4) expressing crypt cells (D3); and some uncharacterized cells expressing Joining Chain Of Multimeric IgA And IgM (JCHAIN) (D4). In gastric, these are: chromogranin (CHGA) expressing enteroendocrine cells (G1); gastrokinin (GKN1) and trefoil factor 1 (TFF1) expressing foveolar cells (G2); and mucin 6 (MUC6) and TFF1 expressing mucus neck cells (G3). Of note, the proton pump gene ATP4A and the intrinsic factor gene GIF were rarely detectable in gastric cells indicating these are cardiac-type gastric samples (Extended Data Figure 1 ).
Interestingly, four clusters were identified in the esophageal samples. Two of these express expected squamous genes (KRT5, KRT14, TP63; clusters E1 and E2) and two express the columnar genes TFF2 and TFF3 (clusters E3 and E4). The two squamous clusters can be distinguished by presence (E1) or absence (E2) of acute phase response (SAA1) gene expression, representing squamous cells in different states. The expression of TFF2 and TFF3 in E3 and E4 is consistent with these cells being from the columnar epithelium of esophageal gland complexes (ESGCs) 19 , an infrequent structure in normal esophagus. For confirmation of this expression pattern, we examined TFF3 and KRT14 protein expression by immunohistochemistry in five normal squamous esophagus resection specimens. As expected, KRT14 was present in squamous epithelium and TFF3 was detected in an esophagus section with clearly defined ESGCs (Figure 1e) . These results show that single cell transcriptomic analysis can identify gastrointestinal epithelial cell subpopulations, including rare cell populations from ESGCs that cannot be distinguished by conventional RNA-seq.
Barrett's esophagus is enriched for LEFTY1 expressing cells
To identify genes characteristic of distinct BE cell populations we clustered all the BE cells by gene expression (Figure 2a , also see Supplementary Table 1 ). The clusters (B1-B4) can be distinguished by expression of MUC2 (B1; goblet cells); LEFTY1 (B2 and B3, approximately 71% of BE cells); and CHGA (B4; enteroendocrine cells). KRT7 is expressed similarly across all 4 clusters, consistent with its clinical utility in BE diagnosis. The different expression patterns of MUC2, LEFTY1 and CHGA can also be consistently seen at the protein level in 41 sections from 19 patients (Extended Data Table 2); for example, morphologically identifiable goblet cells are positive for MUC2 but not LEFTY1 or CHGA (Figure 2b) .
The LEFTY1 expressing cells (B2 and B3; Figure 2a ) are divided into a larger low proliferating (MKI67 (Ki67) negative) cluster (B2) and a smaller high proliferating (MKI67 positive) cluster (B3). LEFTY1, a secreted protein and transforming growth factor beta (TGF-β) superfamily member, is normally expressed in development, where it has roles in left-right asymmetry determination 20 , but little is known about potential roles in adult tissues and it has not previously been associated with BE. LEFTY1 expression was rare in duodenal and gastric cells, compared to BE (Extended Data Figure 2 ).
Esophageal gland complexes share a transcriptional profile with Barrett's esophagus
Taking all cells from BE patients together, the normal tissue cells from the four BE patients separate clearly based on their gene expression, but the BE cells overlap with a sub-set of esophageal cells, as seen in a t-Distributed Stochastic Neighbor Embedding (t-SNE) plot (Figure 3a) . Clustering by gene expression (by the same method as in Figure 1d ) assigned cells to 7 clusters (with brain controls in a separate cluster) (Figure 3b (Figure 1d ) and they can be related to known cell types based on expression of previously characterised genes (Extended Data Figure 3c , also see Supplementary Table 2 for complete list). The majority of duodenal cells fall in the cluster categorised as 'enterocytes' (similar to D1), gastric as 'mucus neck' (similar to G3), and a substantial proportion of esophageal cells are in the 'squamous' cluster (similar to E1/E2) ( Figure 3c ). Some esophageal cells, BE cells and a few duodenal cells fall into a 'goblet' cluster, and some gastric cells cluster with a few BE cells in the 'enteroendocrine' cluster.
The group described as 'non-epithelial' contains some endothelial cells and CD45-low immune cells (Extended Data Figure 4) . Notably, the majority of BE cells (63%) are in the cluster labelled as 'Barrett's-type' that also contains the subset of esophageal cells that have a gene expression profile consistent with their being ESGCs (Figure 3c , also see Supplementary Table 2 ). These cells are highly enriched for LEFTY1.
To test whether this relationship between BE and native esophageal cells with columnar characterization was also seen in patients without BE, we clustered all normal esophagus cells from patients with and without BE groups, using genes differentially expressed between the squamous and Barrett's type groups in Figure 2 . This confirmed that these cells were present in every BE patient sampled, and one patient without BE (Extended Data Figure 5 ).
To confirm whether the relationship between BE cells and ESGCs was stronger than
associations with other gland-type cells, we looked across the transcriptional relationships of cells from other tissues, i.e. gastric gland cells and BE cells that did not express CHGA or 1 0 cells). Comparing entropies of different cell type combinations showed that the BE and ESGC combination had much lower entropy, suggesting this is the strongest relationship (Figure 3d ). t-SNE, with the inclusion of duodenal cells which expressed the highest levels of MUC6 (to enrich for duodenal Brunner's gland-type cells) also showed the strongest strong relationship between BE and ESGC cells (Extended Data Figure 6 ). Collectively, these data show that ESGCs have the greatest transcriptional similarity to BE cells.
ITLN1 and SPINK4 mark early goblet cells
In this study, 19% of BE cells from all patients were classified as 'goblet' cells (Figure 3c and Figure 4a ), which is consistent with the requirement in some countries, such as the US 21 , for goblet cells to be present for the diagnosis of BE. Goblet cells are classically defined by morphological appearance and MUC2 expression. Applying a threshold set at the tenth centile to include 90% of cells in which at least one transcript was detected from each gene (to reduce biological noise), we found that MUC2 transcriptionally co-expressed with intelectin 1 (ITLN1) and Kazal type 4 serine peptidase inhibitor (SPINK4) in 61% of goblet cells from duodenum, gastric and BE samples (Figure 4a,b ). ITLN1 and SPINK4 have been previously shown to mark goblet cells in normal gut and some non-gastrointestinal tissues 22,23 , but we observed some cells in each tissue type that uniquely expressed MUC2, ITLN1 or SPINK4. Therefore we hypothesized that their expression pattern might mark stages of goblet cell development in vivo. To test this we analysed expression of these proteins by immunostaining 5 human intestinal samples (approximately 500 crypts examined in each sample). ITLN1 and SPINK4 co-staining was consistently present near the crypt base, where undifferentiated cells occur, whereas MUC2 staining was in cells toward the centre and top of the crypts, where terminally differentiated cells are found (Figure 4c ). This suggests that ITLN1 and SPINK4 mark an earlier stage of goblet cell differentiation than MUC2 in intestine. 1 1 In ESGCs present beneath the mucosa in sections from three patients with BE, we observed that acinar cells consistently co-expressed ITLN1 and SPINK4 without MUC2 (Figure 4d ).
In 30 BE sections from 16 patients we also consistently observed cells expressing ITLN1 or SPINK4 without MUC2 (Figure 4e , also see Extended Data Table 3 ). Specifically, in specimens from 5 patients, 41% of MUC2 low cells expressed SPINK4 and/or ITLN1, whereas 28% of cells expressed MUC2 alone (Extended Data Table 4 ). These data suggest that ESGCs and BE may contain early goblet cells, as seen in the colon, and that ITLN1 or SPINK4 might mark cells with some goblet cell characteristics that are not yet morphologically identifiable as goblet cells.
OLFM4 marks stem-like transcriptional behaviour in columnar esophageal epithelium
A recent study showed that BE contains pluripotent cells 24 . We therefore analysed all BE and ESGC cells using StemID, which is a published workflow designed to find cells with stemlike properties in single cell RNA-seq data by calculating a 'stem-ness' score based on the entropy of cell clusters and the number of links between clusters 25, 26 . As a control we analysed duodenum cells and found the highest scoring cluster (Extended Data Figure 7a 29, 30 . Consistent with this, we detected OLFM4 protein in human colon crypt bases, where stem cells are known to be located (Figure 5e ). In 8 BE sections from 7 patients, we observed that OLFM4 protein expression was less restricted to the crypt base (Figure 5f, top) , similar to previous observations of LGR5 expression patterns in BE 11 . In ESGCs beneath normal squamous epithelium, OLFM4 positive cells were seen within the gland structures (Figure 5f, bottom) .
Notably, OLFM4 has higher mean expression in the LEFTY1-positive clusters (B2/B3) compared to the clusters expressing known markers of the differentiated goblet (MUC2) and enteroendocrine (CHGA) lineages (Figure 2a , B1 and B4, respectively). To examine coexpression of OLFM4, LEFTY1, MUC2 and CHGA in individual cells we applied a threshold at the tenth centile to include 90% of cells in which at least one transcript was detected from each gene. Using this threshold, half of the BE cells express LEFTY1 and OLFM4, alone or in combination (29% OLFM4 and LEFTY1; 13% OLFM4 only; 11% LEFTY1 only). LEFTY1
and OLFM4 positive BE cells rarely co-expressed MUC2 or CHGA (Extended Data Figure   7e ). Together, these data suggest that B2/B3 represent a cell population that harbours BE progenitor cells.
Discussion
Our single cell RNA-seq data has resolved cell sub-populations in gastrointestinal epithelia and shown a profound transcriptional similarity between ESGC cells and the largest subpopulation of BE cells. This is supported by our observation that this sub-population of BE cells and ESGCs expresses the stem cell-associated gene OLFM4, consistent with the notion that these populations might contain similar progenitor cells. Our findings support a potential model in which acid reflux-induced damage to the esophagus is 'repaired' by the expansion or selection of ESGCs, which have alkaline secretions and are thus able to play a role in protecting the esophagus from gastroesophageal reflux damage. Further consideration of the functional overlap of other secretory structures with BE and ESGCs, such as salivary and mammary glands may help develop our understanding of the adaptive response to injury that drives metaplasia.
During development of the esophagus, glandular epithelial cells are replaced by squamous epithelium and it has been suggested that the ESGCs can be viewed as a developmental 'remnant' 31 . This is consistent with our observations of expression of the developmental gene LEFTY1 in ESGCs and BE. Notably, LEFTY1 is regulated by TGF-β signalling 32 and TGF-β is often perturbed in BE 33 , so it will be interesting to explore this relationship further.
Given that rodents lack ESGCs, and the lack of an in vitro model of human esophageal glands, analysis of human biopsies currently provides the most reliable approach to dissect the cell relationships of BE. Future improvements in single cell DNA sequencing techniques may enable more systematic genetic confirmation of the cellular origin of BE. Also, it is important to note that our study has not investigated potential origins of EAC. Future studies are needed to address the cell relationships of BE and EAC and how this relates to recent work suggesting that EAC is highly similar to a sub-set of gastric cancers 34 .
We showed that SPINK4 and ITLN1 seem to identify an earlier stage of intestinal metaplasia than marked by MUC2, given that they are expressed lower in intestinal crypts than MUC2 and can be seen without MUC2 in BE. Of clinical importance, our results suggest that intestinal goblet cell characteristics exist even without the presence of morphologically identifiable goblet cells, supporting the view that diagnosis of BE should not require the detection of goblet cells. Together, our findings help characterize BE in humans and will have clinical implications by providing a molecular basis to improve diagnosis of BE. In excluding gastric and BE cells that expressed CHGA or MUC2 (to exclude enteroendocrine and goblet cells, respectively) and excluding esophageal cells that did not express TFF3 (to exclude squamous cells). Thresholds were set at the tenth centile of cells in which at least one transcript was detected from each gene. 
Extended Data Figure 4. Characterisation of 'non-epithelial' cells by gene expression:
Heatmap of gene expression in cells in the cluster labelled as 'non-epithelial', showing genes significantly upregulated in this cluster (>4 fold, genes significant at 5% permutation test). scRNA-seq and Bulk RNA-seq indicate whether samples from each patient were used for single cell or bulk RNA-seq, respectively.
Extended Data Table 2. Summary of immunohistochemical staining of BE specimens
Integers denote the number of sections (one section per slide) immunohistochemically stained for each antibody. A total of 81 sections were stained from 19 patients. Basic pathological Figure S6a) . Patients were selected based on their previously known pathological features (Table S1 ). 36 antibodies were added to cell suspensions to identify epithelial and immune cells, respectively, and they were incubated/washed according to manufacturer's advice. DAPI (1:2000, Sigma-Aldrich®) was added to cell suspensions immediately prior to sort. FACS was carried out using a BD Biosciences FACS Aria IIIu platform with 70μm nozzle. Cells were selected based on size and singlet gating to saturate cell output while minimising debris passed to subsequent gates.
Cell isolation
High EpCAM+ cells were then selected (where an abundance of cells were available) to ensure epithelial provenance was maximised (Figure S6b) 
Data analysis
All data were mapped using STAR 39 SC3 41 was used to provide cell cluster information. Cluster robustness to experimental technical variation was tested using BEARscc 42 which models technical noise from ERCC measurements. Cluster number, k, was chosen manually using the distribution of cluster-wise mean silhouette widths across clusters in all 250 simulated technical replicates for each cluster number k (2 to 8 for individual tissue and 1 to 15 for all tissues). t-SNE data were generated using the Barnes-Hut implementation of t-SNE 43 in R. Cluster entropies were calculated using NMF 44 in R. Differential expression analysis was carried out between cell groups using edgeR 45 from normalized counts according to the package manual. P values used were determined by permutation test at 5% (250-1000 permutations) to allow for multiple comparisons or, in cases of unbalanced sample numbers, converted to false discovery rates (FDR) by the Benjamini-Hochberg procedure. Identification of stem-like cells was performed using RaceID2 and StemID according to the authors' recommendations 25, 26 .
Where gene expression is described in binary terms, the threshold was set to include or exclude 90% of cells with the highest expression of a given gene, to allow for biological noise.
Immunohistochemistry and immunofluorescence staining of human tissue
Esophageal samples from esophagectomy specimens (5 patients) containing normal mucosa and gland structures and endoscopic mucosal resection specimens (30 patients) with Barrett's esophagus were obtained from the Oxford biobank. Sections were de-waxed, rehydrated and incubated with 3% hydrogen peroxide in methanol to block endogenous peroxidase activity (10 minutes). Antigen retrieval carried out using pH6 sodium citrate Sections were then blocked with normal goat serum and incubated overnight at 4 °C with a primary antibody against anti-KRT14 (IHC, 1:1000, rabbit polyclonal, cat. PRB-155P, BioLegend), anti-TFF3 (IHC, 1:1000, mouse monoclonal, cat. WH0007033M1, Sigma-Aldrich®) 46 53 . For immunohistochemical staining samples were then treated with biotinylated secondary antibody (Vector Labs; 1:250) for 40 minutes at room temperature. The staining reaction was worked up using the Vector Elite ABC kit and counterstained with haematoxylin. Samples were examined by a pathologist using a histology microscope. For immunofluorescent staining expression was detected using Alexa Fluor (1:250, Molecular Probes) for one hour.
DAPI (1:2000, Sigma-Aldrich®) was used to stain nucleic acids. Samples were observed using a confocal microscope system (LSM 710; Carl Zeiss).
